Dr. Brian Jahns is an accomplished senior executive whose extensive experience spans healthcare, pharma and biotech, mature organizations and start-ups. During his career, Brian fulfilled progressive clinical and business roles at Hoffmann-La Roche Ltd. He then went on to become Senior Vice President, Commercial and Business Development of Trillium Therapeutics (NASDAQ/TSX:TRIL), consulted for a several pre-clinical and clinical stage companies, and ultimately joined Vasomune as President and Chief Operating Officer. Prior to joining pharma, Dr. Jahns completed a Fellowship in Clinical Toxicology at University of Illinois & Cook County Hospital, and was Boarded as a Diplomate of the American Board of Applied Toxicology.